Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.
Press releases published on July 10, 2025
22% de la production initiale de la mine O'Brien dans la robuste EEP est attribuée aux droits exclusifs d’exploration de la redevance mine d'or Kewagama de Globex
GlobeNewswire
·
July 10, 2025
ROUYN-NORANDA, Québec, 10 juill. 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …
Taseko Announces Improved Economics for Yellowhead Copper Project
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the "Company") today announced the results of the recently completed technical report for its 100%-owned Yellowhead …
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
GlobeNewswire
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
GlobeNewswire
·
July 10, 2025
PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
GlobeNewswire
·
July 10, 2025
BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9th International Calicivirus Conference being …
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
GlobeNewswire
·
July 10, 2025
NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Maxus Mining Announces 2025 Exploration Program at its Penny Copper Project
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to provide a summary of the 2025 exploration program (the “Program”) planned on its Penny Copper Project (the “ …
Aventis Energy Announces Partnership with KorrAI Technologies
GlobeNewswire
·
July 10, 2025
Highlights: The Company will leverage KorrAI’s revolutionary systems across the Project with aim to be more efficient in the potential discovery of mineralized outcrops. The cost-efficient technology integrates artificial intelligence, machine learning, …
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
GlobeNewswire
·
July 10, 2025
JUPITER, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Pelthos Therapeutics Inc. (NYSE American: PTHS) has commercially launched ZELSUVMI™ (berdazimer) topical gel 10.3%, the …
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
GlobeNewswire
·
July 10, 2025
ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 (GLOBE NEWSWIRE) -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos …
Vixor Announces $2M Seed Round to Redefine Market-Making with Free, Automated Liquidity Management
GlobeNewswire
·
July 10, 2025
VICTORIA, Seychelles, July 10, 2025 (GLOBE NEWSWIRE) -- Vixor has officially launched its $2 million Seed Round, raising capital to fuel the growth of its free, fully automated market-making platform. With this raise, Vixor aims to help crypto projects of …
Ero Copper Intercepts 105 Meters at 1.54% CuEq¹ at Furnas Copper-Gold Project – Successfully Completes Phase 1 Drill Program
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) is pleased to announce the completion of its Phase 1 drill program at the Furnas Copper-Gold Project ("Furnas" or the "Project"), …
NexGold Infill Drilling Continues to Intersect High-Grade Gold Mineralization at the Goldboro Gold Project, Including 77.30 g/t over 1.25 metres and 19.32 g/t gold over 3.50 metres
GlobeNewswire
·
July 10, 2025
TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …
Pasinex Announces Closing of Shares for Debt Settlement
GlobeNewswire
·
July 10, 2025
TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced that it has issued 28,766,306 common shares to certain of its creditors (the “Settlement Shares”) in exchange for …
Kiniero Grade Control Drilling Continues To Return High-Grade Gold Results
GlobeNewswire
·
July 10, 2025
QUEBEC CITY, July 10, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (ASX: RXR | TSX-V: RBX | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report results from the Mansounia grade control …
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
GlobeNewswire
·
July 10, 2025
ZUG, Switzerland, July 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as …
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
GlobeNewswire
·
July 10, 2025
- Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors Rome, Italy, 10th July 2025 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and …
Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
MEXC DEX+ Super Fest Season 5 Launches with a 200,000 USDT Prize Pool
GlobeNewswire
·
July 10, 2025
VICTORIA, Seychelles, July 10, 2025 (GLOBE NEWSWIRE) -- MEXC, a global leader in cryptocurrency trading, is proud to announce the launch of Season 5 of the DEX+ Super Fest, featuring an upgraded four-tier reward structure and a total prize pool of 200,000 …